The rise in wholly-owned revenue from continuing operations, reported on a constant currency basis, was driven by volume growth of 2.4% and pricing growth of 0.9%.
Revenue from acquisitions contributed 3.3%.
Total group revenue, including Glanbia's share of joint ventures and associates, climbed 13.5% on a reported basis and 13.7% on a constant currency basis. This was driven by 2.3% volume growth, 6.4% price improvement and a 5.0% contribution from acquisitions.
The group has repeated its full-year prediction of 7–10% growth in adjusted earnings per share in constant currency.
Glanbia Performance Nutrition (GPN) was said to have delivered “a satisfactory performance” in the first nine months of the year. Revenues increased by 9%, driven by a 2.7% increase in volume. The acquisitions of Amazing Grass and Body & Fit contributed 7.4% to growth.
GPN was predicted to achieve like-for-like branded revenue growth in the mid-single digit range for the full year, reflecting a seasonal uplift in the fourth quarter.
Full-year earnings before interest, tax and amortisation were expected to be in the mid-teen range, which would be in line with this year’s half-year levels.
The firm’s group md Siobhán Talbot said: “Glanbia delivered a good result in the first nine months of 2017 with wholly-owned revenue from continuing operations growing 6.6% in the period. Glanbia Performance Nutrition was the main driver of revenue growth with Glanbia Nutritionals continuing to perform well.
“Our joint ventures delivered strong revenue growth as a result of improved dairy markets. The outlook for the remainder of 2017 is positive …”.
Meanwhile, in six-month results posted in August, Glanbia revealed a 9.9% rise in group revenue, in constant currency, to £1.67bn (€1.85bn). The results followed its decision to start a new venture and to sell 60% of its Dairy Ireland business.